These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 6228029)
1. Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease. Thaulow E Thromb Haemost; 1983 Oct; 50(3):629-32. PubMed ID: 6228029 [TBL] [Abstract][Full Text] [Related]
2. Effects induced on blood platelets in ischemic and nonischemic myocardium. Thaulow E Am J Cardiol; 1983 Sep; 52(5):466-9. PubMed ID: 6225328 [TBL] [Abstract][Full Text] [Related]
3. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease]. Terres W; Schuster O; Kupper W; Bleifeld W Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
8. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy. Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527 [TBL] [Abstract][Full Text] [Related]
9. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110 [TBL] [Abstract][Full Text] [Related]
10. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947 [TBL] [Abstract][Full Text] [Related]
11. Influence of triflusal on platelet activation after coronary artery bypass graft. Prieto MA; De La Cruz JP; Del Prado MF; Sánchez de la Cuesta F Blood Coagul Fibrinolysis; 2000 Mar; 11(2):191-7. PubMed ID: 10759013 [TBL] [Abstract][Full Text] [Related]
12. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358 [TBL] [Abstract][Full Text] [Related]
13. Platelet activation during steady state sickle cell disease. Westwick J; Watson-Williams EJ; Krishnamurthi S; Marks G; Ellis V; Scully MF; White JM; Kakkar VV J Med; 1983; 14(1):17-36. PubMed ID: 6224876 [TBL] [Abstract][Full Text] [Related]
14. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. Schumacher WA; Lucchesi BR J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881 [TBL] [Abstract][Full Text] [Related]
15. Intracoronary platelet release in patients with and without coronary artery disease. Verheugt FW; Serruys PW; van Vliet H; Spijkers A; Hugenholtz PG Thromb Haemost; 1983 Feb; 49(1):28-31. PubMed ID: 6221435 [TBL] [Abstract][Full Text] [Related]
16. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625 [TBL] [Abstract][Full Text] [Related]
17. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination. Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133 [TBL] [Abstract][Full Text] [Related]
18. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor. Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042 [TBL] [Abstract][Full Text] [Related]
19. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome. Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747 [TBL] [Abstract][Full Text] [Related]
20. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood. Zhang QH; Das K; Siddiqui S; Myers AK Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]